- Home
- Publications
- Publication Search
- Publication Details
Title
11C-Choline PET/CT and PSA kinetics
Authors
Keywords
Prostate cancer, Choline, PET/CT, PSA kinetics
Journal
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Volume 40, Issue S1, Pages 36-40
Publisher
Springer Nature
Online
2013-04-11
DOI
10.1007/s00259-013-2377-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical impact of 18F-choline PET/CT in patients with recurrent prostate cancer
- (2012) Jan D. Soyka et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Influence of PSA, PSA velocity and PSA doubling time on contrast-enhanced 18F-choline PET/CT detection rate in patients with rising PSA after radical prostatectomy
- (2012) Orazio Schillaci et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Impact of total PSA, PSA doubling time and PSA velocity on detection rates of 11C-Choline positron emission tomography in recurrent prostate cancer
- (2012) Maxim Rybalov et al. WORLD JOURNAL OF UROLOGY
- Relationship between PSA kinetics and [18F]fluorocholine PET/CT detection rates of recurrence in patients with prostate cancer after total prostatectomy
- (2011) Vera Graute et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Pelvic/Retroperitoneal Salvage Lymph Node Dissection for Patients Treated With Radical Prostatectomy With Biochemical Recurrence and Nodal Recurrence Detected by [11C]Choline Positron Emission Tomography/Computed Tomography
- (2011) Patrizio Rigatti et al. EUROPEAN UROLOGY
- [18F]fluoroethylcholine-PET/CT imaging for radiation treatment planning of recurrent and primary prostate cancer with dose escalation to PET/CT-positive lymph nodes
- (2011) Florian Würschmidt et al. Radiation Oncology
- Influence of 11C-choline PET/CT on the treatment planning for salvage radiation therapy in patients with biochemical recurrence of prostate cancer
- (2011) Michael Souvatzoglou et al. RADIOTHERAPY AND ONCOLOGY
- Is there a role for 11C-choline PET/CT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase
- (2010) Paolo Castellucci et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- PSA doubling time for prediction of [11C]choline PET/CT findings in prostate cancer patients with biochemical failure after radical prostatectomy
- (2010) Giampiero Giovacchini et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- The Role of Choline Positron Emission Tomography/Computed Tomography in the Management of Patients with Prostate-Specific Antigen Progression After Radical Treatment of Prostate Cancer
- (2010) Maria Picchio et al. EUROPEAN UROLOGY
- Clinical evidence on PET/CT for radiation therapy planning in prostate cancer
- (2010) Maria Picchio et al. RADIOTHERAPY AND ONCOLOGY
- Predictive factors of [11C]choline PET/CT in patients with biochemical failure after radical prostatectomy
- (2009) Giampiero Giovacchini et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Influence of Trigger PSA and PSA Kinetics on 11C-Choline PET/CT Detection Rate in Patients with Biochemical Relapse After Radical Prostatectomy
- (2009) P. Castellucci et al. JOURNAL OF NUCLEAR MEDICINE
- 11C-Choline Positron Emission Tomography/Computerized Tomography for Preoperative Lymph-Node Staging in Intermediate-Risk and High-Risk Prostate Cancer: Comparison with Clinical Staging Nomograms
- (2008) Riccardo Schiavina et al. EUROPEAN UROLOGY
- Novel Tracers and Their Development for the Imaging of Metastatic Prostate Cancer
- (2008) A. B. Apolo et al. JOURNAL OF NUCLEAR MEDICINE
- A Model That Predicts the Probability of Positive Imaging in Prostate Cancer Cases With Biochemical Failure After Initial Definitive Local Therapy
- (2008) Toni K. Choueiri et al. JOURNAL OF UROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More